Pfizer keeps 2022 COVID-19 vaccine, pill sales outlook unchanged - Al Jazeera English
5/3/2022 12:00:00 AM3 years 10 months ago
by Al Jazeera
by Al Jazeera
The move disappointed investors who were hoping products would continue to drive growth.
Pfizer Inc. kept its outlook for annual sales of its Covid-19 vaccine and treatment, disappointing investors who looked for the products to continue driving growth. Through mid-April, Pfizer said it… [+4330 chars]
full article...